News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17605)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Lone Star Bio
Oncolix Announces Submission of Application for Listing on OTC-QB
The review is anticipated to take approximately two to four weeks after which Oncolix would be listed on the OTC-QB.
December 6, 2017
·
3 min read
Biotech Bay
Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017
Management to be joined by external guest speaker to review imetelstat data from IMerge to be presented at the 59th American Society of Hematology Annual Meeting and Exposition.
December 6, 2017
·
1 min read
BioMidwest
Libella Gene Therapeutics Announces Experimental Research Project in Hopes of Reversing ALZ’s
The experimental research project will treat a limited number of patients using gene therapy treatment to lengthen telomeres.
December 6, 2017
·
3 min read
BioMidwest
New Promega Maxwell RSC PureFood Pathogen Kit Offers Food Labs Quick, Consistent Automated DNA Purification
The kit does not require enzymatic pre-treatment and, when used in combination with the Maxwell RSC Instrument, can effectively purify DNA from 1 to 16 food matrix samples in 40 minutes, saving time for those who need to make quick decisions about potential food spoilage and contamination.
December 6, 2017
·
3 min read
Pharm Country
The Leukemia Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer
More than 150 patients are now enrolled in this innovative trial which aims to find new treatments for a blood cancer that has not seen significant treatment improvements in almost 40 years.
December 6, 2017
·
6 min read
Business
Inovio Pharmaceuticals Appoints Wendy Yarno to Its Board of Directors
Wendy Yarno has over 25 years of experience in the pharmaceutical industry highlighted by her tenure at Merck where she served as chief marketing officer.
December 6, 2017
·
4 min read
Biotech Beach
ImpediMed Launches FDA-Approved SOZO
ImpediMed announced the launch of its new product, SOZO.
December 6, 2017
·
4 min read
Pharm Country
OrCam to Launch Next Generation of Artificial Vision
OrCam MyEye 2.0 is the culmination of intense research and development by leading minds in the Computer Vision and Machine Learning fields.
December 6, 2017
·
3 min read
Drug Development
Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer
The Phase Ib/IIa study will evaluate the safety, activity and pharmacokinetics of escalating doses of GNS561.
December 6, 2017
·
3 min read
Business
Vaxil Strengthens Board of Directors and Management Concurrent to $1M Financing
Vaxil Bio is pleased to announce the addition of two veteran healthcare executives to its Board of Directors.
December 6, 2017
·
4 min read
Previous
10 of 15
Next